May 11, 2020
19,507
388
150
2.76%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
45:24Now PlayingIn part 2 of this special edition episode, Tony – along with his friend Dr. Peter Diamandis, the Harvard Medical School trained M.D. and executive founder of Singularity University – explore the present and future of COVID-19.
Tony and Peter speak with Mei Mei Hu and Lou Reese, Co-CEOs of United Biomedical, a company that is now offering an affordable and accurate diagnostic test for COVID-19 through its subsidiary, COVAXX
Their antibody test is different from others, as it can detect not only if you currently have the virus, but also it signals if you’ve ever had the virus, which is crucial in determining the true rate of mortality associated with COVID-19 – and whether people are immune and therefore able to stop isolating, and go back to work.
Lou and Mei Mei’s team at COVAXX is also working on a breakthrough alternative option to a traditional vaccine for coronavirus, which you’ll hear discussed in the last half of the episode.
View Part One Here
Get a FREE copy of Unshakable
Follow TR:
Tony Robbins is a #1 New York Times best-selling author, entrepreneur, and philanthropist. For more than 37 years, millions of people have enjoyed the warmth, humor and dynamic presentation of Mr. Robbins' corporate and personal development events. As the nation's #1 life and business strategist, he's called upon to consult and coach some of the world's finest athletes, entertainers, Fortune 500 CEOs, and even presidents of nations.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.